PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $40,852,372 | 15.05% |
Kynam Capital Management, LP | 1,818,657 | $30,335,199 | 4.96% |
BVF INC/IL | 5,744,848 | $95,824,065 | 2.58% |
Ghost Tree Capital, LLC | 400,000 | $6,672,000 | 2.19% |
COWEN AND COMPANY, LLC | 1,657,551 | $27,647,950 | 1.93% |
RTW INVESTMENTS, LP | 5,415,514 | $90,330,774 | 1.91% |
Sio Capital Management, LLC | 248,127 | $4,138,758 | 1.28% |
683 Capital Management, LLC | 732,784 | $12,222,837 | 0.95% |
Artia Global Partners LP | 112,340 | $1,873,831 | 0.78% |
Perceptive Advisors | 1,054,273 | $17,585,274 | 0.59% |